Cite
Induction of RIPK3/ MLKL-mediated necroptosis by Erigeron breviscapus injection exhibits potent antitumor effect.
MLA
Xiuping Guo, et al. “Induction of RIPK3/ MLKL-Mediated Necroptosis by Erigeron Breviscapus Injection Exhibits Potent Antitumor Effect.” Frontiers in Pharmacology, Sept. 2023, pp. 1–16. EBSCOhost, https://doi.org/10.3389/fphar.2023.1219362.
APA
Xiuping Guo, Rui Li, Jinjin Cui, Chujuan Hu, Haoyang Yu, Ling Ren, Yangyang Cheng, Jiandong Jiang, Xiao Ding, & Lulu Wang. (2023). Induction of RIPK3/ MLKL-mediated necroptosis by Erigeron breviscapus injection exhibits potent antitumor effect. Frontiers in Pharmacology, 1–16. https://doi.org/10.3389/fphar.2023.1219362
Chicago
Xiuping Guo, Rui Li, Jinjin Cui, Chujuan Hu, Haoyang Yu, Ling Ren, Yangyang Cheng, Jiandong Jiang, Xiao Ding, and Lulu Wang. 2023. “Induction of RIPK3/ MLKL-Mediated Necroptosis by Erigeron Breviscapus Injection Exhibits Potent Antitumor Effect.” Frontiers in Pharmacology, September, 1–16. doi:10.3389/fphar.2023.1219362.